The 2022 Annual Conference of ISHR-NAS: Advances in Cardiovascular Medicine Through Diversity, Equity, and Inclusion; Focusing on Education and Technological Innovation
The 2022 Annual Conference of ISHR-NAS: Advances in Cardiovascular Medicine Through Diversity, Equity, and Inclusion; Focusing on Education and Technological Innovation
批准号:
10540615
负责人:
Peipei Ping
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-07-31
关键词:
AcademiaAdministratorAdvocateAgingAmericanAwardBasic ScienceBig DataBiologyCanadaCardiac healthCardiovascular DiseasesCardiovascular systemCareer MobilityCitiesClinical SciencesColoradoCommunitiesDevelopmentDiagnosisDisciplineDiseaseEducationEducational workshopEnvironmentEpigenetic ProcessEvaluationEventFemaleFosteringFriendsFunctional disorderFunding AgencyGenerationsGoalsGovernmentGrowthHealthHeart DiseasesHeart ResearchHeart failureIndividualIndustrializationIndustryInstitutionInternationalInvestmentsKnowledgeLeadershipLocationLogisticsMarriageMedicineMetabolismMinority GroupsMissionMolecularNational Heart, Lung, and Blood InstituteNutritional statusParticipantPhasePhenotypePhysiciansPlant RootsPreventionPrevention strategyPrivate SectorProteomicsPublished CommentRequest for ProposalsResearchResearch PersonnelRoleScheduleScienceScientistSeriesSocietiesSystemTechnologyTrainingTranslatingTranslationsTravelUnderrepresented MinorityWomanacademic programbasecardiovascular healthcareerclinical practicecommunity buildingdisorder preventiondiversity and equityeducation researchexperiencegender differencehormone therapyinnovationinsightlecturesmeetingsmembernovelnovel strategiesoperationprogramsrapid growthsuccesssymposiumtechnological innovationtranslational medicine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal requests NHLBI’s support for the 41st Annual Conference of the International Society for Heart
Research (ISHR)—North American Section (NAS) in 2022. As the current President of ISHR-NAS (2018-2021),
it is my great honor to serve as the PI of this R13 application and together with my colleagues on the NAS
leadership team, Dr. Lorri Kirshenbaum (conference chair), Dr. Maria Kontaridis and Dr. Jennifer Van Eyk
(conference co-chairs), Dr. David Lefer, the next NAS President (2022-2024), and Ms. Kelley Brodsky (Executive
Administrator), we will continue the success in ISHR-NAS meetings. Our ISHR-NAS 2021 meeting in Denver
was an excellent success; we are confident based on the steady growth of NAS membership over the past four
years that this 2022 meeting will attract approximately 250-300 attendees. Since spring of 2021, we have been
working together to plan a first-class conference with broad impact in cardiovascular biology and medicine.
Together, the meeting organizers have extensive experience in implementing national and international
conferences, and our scientific expertise covers a broad range of disciplines. We fully anticipate that this
outstanding team will make the 2022 ISHR-NAS conference another riveting success.
Our goals will be supported by these aims: Aim 1 is to elevate and enrich the careers of young investigators in
order to facilitate their launch. Aim 2 is to illuminate recent scientific developments in unique cardiovascular
domains via the marriage of basic and clinical science with industrial participation. Aim 3 is to present state-of-
the-art cardiovascular science through interactive domains, including panel discussions where candid, direct
debates on challenges and important issues faced by the cardiovascular community are emphasized. Many
components of the meeting are deeply rooted in promoting Diversity, Equity, and Inclusion in cardiovascular
medicine.
This meeting contains a vibrant scientific program that features special 1-day sessions for ECIs and MCIs, 21
scientific symposia, 2 young investigator competitions, 5 workshops, 3 featured lectures, and several community-
building networking events. The preliminary program contains a total of 104 invited speakers and panelists
(~80% confirmed, 51% are female), representing premier academic programs and industrial research entities
located from 35 cities across 24 States in the US and 6 cities in Canada. By implementing mechanisms to
maximize the participation of female and URM speakers, this meeting offers valuable opportunities to support
the ISHR-NAS mission on Diversity, Equity, and Inclusion. The preliminary program consists of greater than
50% female. Moreover, we have allocated 30 travel awards specifically for underrepresented minority groups
(URMs) in order to further promote equality and equal opportunities. Every aspect of the meeting will go to
support the NHLBI mission of promoting the prevention and treatment of heart diseases and enhancing the
health of individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Omics Phenotyping for Identifying Molecular Signatures of the Healthy and Failing Heart: An Integrated Data Science Platform
-
批准号:10560520
-
项目类别:
-
资助金额:$91.07万
-
财政年份:2017
-
负责人:Peipei Ping
-
依托单位:
Omics Phenotyping for Identifying Molecular Signatures of the Healthy and Failing Heart: An Integrated Data Science Platform
-
批准号:10327640
-
项目类别:
-
资助金额:$91.07万
-
财政年份:2017
-
负责人:Peipei Ping
-
依托单位:
Regulation of Protein Dynamics in Heart Failure
-
批准号:8985517
-
项目类别:
-
资助金额:$50.05万
-
财政年份:2015
-
负责人:Peipei Ping
-
依托单位:
Hexokinases and Cardioprotection
-
批准号:9067512
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2013
-
负责人:Peipei Ping
-
依托单位:
Hexokinases and Cardioprotection
-
批准号:8720056
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2013
-
负责人:Peipei Ping
-
依托单位:
Hexokinases and Cardioprotection
-
批准号:8600146
-
项目类别:
-
资助金额:$46.19万
-
财政年份:2013
-
负责人:Peipei Ping
-
依托单位:
Novel Signaling Mechanisms and Molecular Targets in the Stressed Myocardium
-
批准号:8009541
-
项目类别:
-
资助金额:$75.24万
-
财政年份:2010
-
负责人:Peipei Ping
-
依托单位:
TAS::75 0872::TAS PROTEOME BIOLOGY OF CARDIOVASCULAR DISEASE
-
批准号:8175614
-
项目类别:
-
资助金额:$227.35万
-
财政年份:2010
-
负责人:Peipei Ping
-
依托单位:
Novel Signaling Mechanisms and Molecular Targets in the Stressed Myocardium
-
批准号:8476260
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2010
-
负责人:Peipei Ping
-
依托单位:
Novel Signaling Mechanisms and Molecular Targets in the Stressed Myocardium
-
批准号:8277103
-
项目类别:
-
资助金额:$74.49万
-
财政年份:2010
-
负责人:Peipei Ping
-
依托单位:
Novel Signaling Mechanisms and Molecular Targets in the Stressed Myocardium
-
批准号:8099526
-
项目类别:
-
资助金额:$74.49万
-
财政年份:2010
-
负责人:Peipei Ping
-
依托单位:
Role of mitochondria in cardiac protection
-
批准号:7257867
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Peipei Ping
-
依托单位:
Role of mitochondria in cardiac protection
-
批准号:7463899
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Peipei Ping
-
依托单位:
Role of mitochondria in cardiac protection
-
批准号:7882701
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Peipei Ping
-
依托单位:
Role of mitochondria in cardiac protection
-
批准号:7638579
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Peipei Ping
-
依托单位:
Role of mitochondria in cardiac protection
-
批准号:7151877
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2006
-
负责人:Peipei Ping
-
依托单位:
Ischemic Injury and Protection
-
批准号:7433204
-
项目类别:
-
资助金额:$230.98万
-
财政年份:2005
-
负责人:Peipei Ping
-
依托单位:
Ischemic Injury and Protection
-
批准号:7055306
-
项目类别:
-
资助金额:$229.26万
-
财政年份:2005
-
负责人:Peipei Ping
-
依托单位:
Ischemic Injury and Protection
-
批准号:6908618
-
项目类别:
-
资助金额:$227.75万
-
财政年份:2005
-
负责人:Peipei Ping
-
依托单位:
Ischemic Injury and Protection
-
批准号:7231463
-
项目类别:
-
资助金额:$229.05万
-
财政年份:2005
-
负责人:Peipei Ping
-
依托单位:
海外基金